PARP Inhib-Ovarian Breast Cancer Generic

So, Olaparib is this thing called a PARP inhibitor. It’s meant to treat cancers caused by BRCA1 and BRCA2 mutations in ovaries, breasts, pancreases, and prostates. It stops cancer cells from fixing their DNA, which kind of slows them down.

The drug comes in tablets that are either 100 mg or 150 mg and are covered with a film. The usual dose is 300 mg, and you’re supposed to take it twice each day. You can take that amount with or without eating.

These bottles come with 60 tablets each.